Archives

– Results from Phase 2 cervical cancer trial with ISA101 selected for plenary oral presentation

Leiden, The Netherlands, March 28, 2019– ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology company, today announced that its Chief Scientific Officer Prof. Dr. Cornelis Melief will give an oral presentation at the upcoming AACR Annual Meeting 2019 in Atlanta, GA, USA, on March 31, 2019.

The presentation titled “A strong HPV-specific T-cell response after chemo-immunotherapy for advanced cervical cancer is associated with prolonged survival”is scheduled for Sunday, March 31, 2019, as part of the session “Predictive Biomarkers for Immunotherapy” (12:45-2:45pm, Marcus Auditorium- Bldg A-GWCC).

The data will outline the effects of vaccination

– Recognition for outstanding and innovative cancer research

Leiden, The
Netherlands, March 19, 2019 – ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology
company, today announced that its Chief Scientific Officer Prof. Dr. Cornelis
Melief will receive the AACR-CRI Lloyd J. Old Award in Cancer Immunology 2019
from the American Association of Cancer Research (AACR) and the Cancer Research
Institute.

The AACR-CRI
Lloyd J. Old Award in Cancer Immunology recognizes an active scientist whose
outstanding and innovative research has had a major impact on the cancer field
and has the potential to stimulate new directions in cancer immunology.

The award was
established in honor of the late Lloyd J. Old, MD, who is